BeatO receives INR 11.75 Crore funding


Catering to the health relates issues in the Indian economy BeatO provides efficient services like blood sugar level monitoring through glucometer.Catering to the health relates issues in the Indian economy BeatO provides efficient services. The 80 million population of India is suffering from diabetes and it is also growing at over 60% CAGR.

BeatO thus provides a stand alone platform for diabetes monitoring and management of activities with great ease.

After establishment in September 2015, BeatO has raised an undisclosed amount in seed funding in 2017. The eminent investors were Blume Ventures and Leo Capital.

The platform provides regular exercise schedule, controlled diet, medicines and diagnostics with great ease to users. It also provides blood sugar level monitoring with efficient smart phone based glucometer.

Related Article: Ukrainian investor invests in India’s largest online auto components buyers

Also, understanding the trends of growing disposable incomes of Indian households there is a hope of increase in discretionary spends. The platform thus with a personalized touch can expect a rise.

The real time assistance of BeatO platform thus provides efficient medical facility.

Thus, Orios Venture Partner has led INR 11.75 Crore funding to BeatO. Proceeds from Series A funding will allow the Company to expand its flagship glucometer product line into FMCG and Retail Categories.

The Company will also utilize the funding in R&D, platform upgradation for auto-suggestion and product development.

Thus, the founders Gautam Chopra and Yash Sehgal plans to exploit new opportunities and upgrade the quality of services.


Leave a reply

Your e-mail address will not be published. Required fields are marked *

More in Funding